Skip to content

Opening book details…

About this Medicine article

A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Phase 1 Study of AK002, a Novel Siglec-8 Selective Monoclonal Antibody, in Healthy Subjects by Rasmussen, Henrik S.; Chang, Alan T.; Tomasevic, Nenad; Bebbington, Christopher is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Rasmussen, Henrik S.; Chang, Alan T.; Tomasevic, Nenad; Bebbington, Christopher
Publisher
Elsevier Science; Elsevier ; Mosby Inc.; Elsevier BV; SAGE Publications (ISSN 1097-6825)
Published
2018
Language
EN
Field
Medicine (Health Sciences)

More by Rasmussen, Henrik S.; Chang, Alan T.; Tomasevic, Nenad; Bebbington, Christopher

Browse all works by Rasmussen, Henrik S.; Chang, Alan T.; Tomasevic, Nenad; Bebbington, Christopher